These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 1418888

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. A review of clozapine: an antipsychotic for treatment-resistant schizophrenia.
    Stephens P.
    Compr Psychiatry; 1990; 31(4):315-26. PubMed ID: 2201482
    [Abstract] [Full Text] [Related]

  • 43. Clozapine: is another view valid?
    Meltzer HY.
    Am J Psychiatry; 1995 Jun; 152(6):821-5. PubMed ID: 7755109
    [No Abstract] [Full Text] [Related]

  • 44. [Agranulocytosis in a child with schizophrenia treated with clozapine--clinical findings and therapy, a case report].
    Reitzle K, Warnke A, Wewetzer C, Müller H.
    Z Kinder Jugendpsychiatr Psychother; 2001 May; 29(2):137-43. PubMed ID: 11393052
    [Abstract] [Full Text] [Related]

  • 45. [Clinical experience with Leponex].
    Lange E, König L, Kühne GE, Liefke T.
    Psychiatr Neurol Med Psychol (Leipz); 1975 Jun; 27(6):360-5. PubMed ID: 1208707
    [Abstract] [Full Text] [Related]

  • 46. Clozapine-associated neutropenic enterocolitis.
    Beck DA, Miller DD.
    Ann Clin Psychiatry; 1994 Sep; 6(3):185-8. PubMed ID: 7881499
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors.
    Pollmächer T, Hinze-Selch D, Mullington J, Holsboer F.
    Arch Gen Psychiatry; 1995 Oct; 52(10):877-8. PubMed ID: 7575109
    [No Abstract] [Full Text] [Related]

  • 49. Clozapine: benefits and risks.
    Fuchs AM.
    Schizophr Bull; 1994 Oct; 20(1):23-4. PubMed ID: 8197418
    [No Abstract] [Full Text] [Related]

  • 50. Clozapine. Comments by a Sandoz official.
    Westlin WF.
    Hosp Community Psychiatry; 1990 Aug; 41(8):874-6. PubMed ID: 2119335
    [No Abstract] [Full Text] [Related]

  • 51. [Development and implementation of clozapine protocol in patients with schizophrenia in Greece].
    Nystazaki M, Karanikola M, Gartzoni V, Georgou A, Tolia S, Liapis C, Psomiadi M, Alevizopoulos G.
    Psychiatriki; 2020 Aug; 31(1):70-81. PubMed ID: 32544078
    [Abstract] [Full Text] [Related]

  • 52. Clozapine--a potential antipsychotic agent without extrapyramidal manifestations.
    Matz R, Rick W, Oh D, Thompson H, Gershon S.
    Psychopharmacol Bull; 1975 Jan; 11(1):14. PubMed ID: 1121559
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Seizure with low doses of clozapine.
    More J.
    Am J Psychiatry; 1992 Oct; 149(10):1413-4. PubMed ID: 1530089
    [No Abstract] [Full Text] [Related]

  • 55. Notes from a state mental health directors' meeting on clozapine.
    Salzman C.
    Hosp Community Psychiatry; 1990 Aug; 41(8):838-9, 842. PubMed ID: 2401474
    [No Abstract] [Full Text] [Related]

  • 56. Monitoring clozapine.
    Meltzer HY.
    Hosp Community Psychiatry; 1990 Dec; 41(12):1356-7. PubMed ID: 2125973
    [No Abstract] [Full Text] [Related]

  • 57. Extrapyramidal symptoms after addition of fluvoxamine to clozapine.
    Kuo FJ, Lane HY, Chang WH.
    J Clin Psychopharmacol; 1998 Dec; 18(6):483-4. PubMed ID: 9864083
    [No Abstract] [Full Text] [Related]

  • 58. Clozapine.
    Launer M.
    Br J Hosp Med; 1998 Dec; 49(1):56-8. PubMed ID: 8431727
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Prolonged psychotic relapse after abrupt clozapine withdrawal.
    Parsa MA, al-Lahham YH, Ramirez LF, Meltzer HY.
    J Clin Psychopharmacol; 1993 Apr; 13(2):154-5. PubMed ID: 8463447
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.